|
183.
Study of cardiovascular complication in long term DM.
184.
Study of Ciprofloxacin resistance in Typhoid fever.
185.
Study of lipid profile in patients of Type 2 DM and their
first degree relatives.
186.
Clinical profile of Acute poisoning in adult in V.S.S. M.C.
Hospital.
187.
Rosiglitazone in Type 2 DM
188.
Evaluation of efficacy of Arteether
b in Severe F. Malaria.
189.
Clinical Profile and CT evaluation of stroke.
190.
CSF lactate level in cerebral malaria.
191.
Lipid profile in patients in Viral hepatitis.
192.
Study of pentoxyphyline as an adjuvant therapy in the
treatment of F. malaria in S.C Anaemia.
193.
Seroprevalence of Hepatitis B and Hepatitis C virus in S.C.
Haemoglobinopathy.
194.
Study of gliclazide +Metformin versus Gliclazide +Pioglitazone
in obese Type 2 DM in respect to glycemic control.
195.
Study of involvement of foot in DM.
196.
Study of acute phase reactant in pregnancy related malaria.
197.
Clinical profile and prognosis of AMI in DM.
198.
Study of lipoprotein a in Type 2 DM in relation to Diabetic
Vascular complications.
199.
Study of dyslipidemia in CAD with type 2 DM
200.
Clinical , radiological, immunological profile of
neurocystisercosis in W. Orissa.
201.
Role of L- Arginine in S.C. Crisis.
202.
Study of ECG changes in comparison to Serum K+ level in
Periodic paralysis.
203.
Role of Aspartame in SCD specially in S.C. Crisis.
204.
Incidence, aetiopathgenesis , Clinical feature ,
complications of SBP in Cirrhosis.
205.
Aetiopathogenesis, Clinical Profile , management of A.
Fibrillation.
206.
Study of Serum CRP as an indicator of prognosis in AMI.
207.
Study of impaired glucose tolerance , DM and pancreatic
pathlogy in S.C. Haemoglobinoapthy.
208.
Clinical profile, ECG , Cardiac Trop – I in Acute Coronary
Syndrome with special reference to Non-ST elevation.
209.
Estimation of G6PD and pyruvate kinase in SCD.
210.
Clinical feature, ECG, ECHO analysis of Dilated
Cardiomyopathy.
211.
Study of ECG, Clinical Evaluation of RV infarction .
212.
Cortisol level in Malaria.
213.
Correlation of CRP in Acute Ischaemic Stroke in relation to
Lipid.
214.
Study of Lipoprotein (a) as a risk factor in CAD.
215.
Divalent Cation Status in Essential hypertension and
response to different antihypertensive drugs.
216.
Association of Ca+, Mg+ status in cases of Hypokalaemic
periodic palsy.
217.
Neuropsychiatric manifestation of Falciparum malaria.
218.
Relation of Foetal Hb to different complications of SCD.
219.
Rhabdomyolysis in Falciparum Malaria.
220.
Clincial and ECHO findings of AMI below and above 40 years.
221.
Study of relation of Mg+ level with Cardiac arrythmias
following 24 hours of AMI.
222.
Antiatherogenic properties of Pioglitazone in Type 2 DM.
223.
Coagulation profile of Falciparum Malaria.
224.
Vitamin B12 and Folic Acid level in SCD.
225.
Levels of Fibrinogen in Stroke.
226.
CSF and serum CRP in Meningitis in Adult.
227.
Clinical profile of Leptospirosis in Western Orissa.
228.
Study of Plasma homocysteine in patients of DM with special
reference to its correlation with CAD.
229.
Homocysteine as risk factor in CAD.
230.
Serum Lipid Profile in CRF.
231.
Cardiac involvement in CRF.
232.
Pancreatic involvement in Falciparum Malaria.
233.
Pleotropic anti-inflammatory effect of Atorvastatin in Type
2 DM and Syndrome-X.
234.
Bedside CRP in Acute Cough (CAP).
235.
Lipid peroxidation in SCD with Crisis.
236.
Study of Corrected QT interval in Diabetes – an indicator
cardiac autonomic neuropathy. |